{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T14:44:26Z","timestamp":1770475466930,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1986,1,1]],"date-time":"1986-01-01T00:00:00Z","timestamp":504921600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1986]]},"DOI":"10.1007\/bf00613523","type":"journal-article","created":{"date-parts":[[2004,11,25]],"date-time":"2004-11-25T04:23:31Z","timestamp":1101356611000},"page":"449-455","source":"Crossref","is-referenced-by-count":52,"title":["Importance of oxidative polymorphism and levomepromazine treatment on the steady-state blood concentrations of clomipramine and its major metabolites"],"prefix":"10.1007","volume":"31","author":[{"given":"A. E.","family":"Balant-Gorgia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. P.","family":"Balant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ch.","family":"Genet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Dayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. M.","family":"Aeschlimann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Garrone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"35","volume":"Suppl 3","author":"DK Luskombe","year":"1979","unstructured":"Luskombe DK (1979) Pharmacokinetics of clomipramine. Br J Clin Pract (Suppl 3) 35?50","journal-title":"Br J Clin Pract"},{"key":"CR2","first-page":"359","volume-title":"Frontiers in biochemical and pharmacological research in depression","author":"F Sj\u00f6qvist","year":"1984","unstructured":"Sj\u00f6qvist F, Bertilsson L (1984) Clinical pharmacology of antidepressant drugs: Pharmacogenetics. In: Usdin E, \u00c5sberg M, Bertilsson L, Sj\u00f6qvist F (eds) Frontiers in biochemical and pharmacological research in depression. Raven Press, New York, pp 359?372"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/clpt.1982.50","volume":"31","author":"WZ Potter","year":"1982","unstructured":"Potter WZ, Calil HM, Sufin TA, Zavadil AP, Jusko WZ, Rapopert J, Goodwin FK (1982) Active metabolites of imipramine and desipramine in man. Clin Pharmacol Ther 31: 394?401","journal-title":"Clin Pharmacol Ther"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/clpt.1981.147","volume":"30","author":"B Mellstr\u00f6m","year":"1981","unstructured":"Mellstr\u00f6m B, Bertilsson L, S\u00e4we J, Schulz HV, Sj\u00f6qvist F (1981) E and Z-10 hydroxylation of nortriptyline: Relationship to polymorphic debrisoquine hydroxylation. Clin Pharmacol Ther 30: 189?193","journal-title":"Clin Pharmacol Ther"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1365-2125.1983.tb01518.x","volume":"15","author":"L Bertilsson","year":"1983","unstructured":"Bertilsson L, \u00c5sbeg-Wistedt A (1983) The debrisoquine hydroxylation test predicts steady-state plasma of desipramine. Br J Clin Pharmacol 15: 388?390","journal-title":"Br J Clin Pharmacol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF02141782","volume":"232","author":"AE Balant-Gorgia","year":"1982","unstructured":"Balant-Gorgia AE, Schulz P, Dayer P, Balant LP, Gertsch C, Garrone G (1982) Role of oxidation polymorphism on blood and urine concentrations of amitriptyline and its metabolites in man. Arch Psychiatr Nervenkr 232: 215?222","journal-title":"Arch Psychiatr Nervenkr"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF03189547","volume":"7","author":"P Dayer","year":"1982","unstructured":"Dayer P, Balant LP, Courvoisier F, K\u00fcpfer A, Kubli A, Balant-Gorgia A, Fabre J (1982) The genetic control of bufuralol in man. Eur J Drug Metab Pharmacokinet 7: 33?77","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/clpt.1984.212","volume":"36","author":"G Alvan","year":"1984","unstructured":"Alvan G, Griud M, Graffner C, Sj\u00f6qvist F (1984) Relationship of N-demethylation of amiflamine and its metabolite to debrisoquine hydroxylation polymorphism. Clin Pharmacol Ther 36: 515?519","journal-title":"Clin Pharmacol Ther"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/clpt.1984.239","volume":"36","author":"E Spina","year":"1984","unstructured":"Spina E, Birgersson C, von Bahr C, Ericsson \u00d6, Mellstr\u00f6m B, Sheiner E, Sj\u00f6qvist F (1984) Phenotypic consistency in hydroxylation of desmethylimipramine and debrisoquine in healthy subjects and in human liver microsomes. Clin Pharmacol Ther 36: 677?682","journal-title":"Clin Pharmacol Ther"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1159\/000137324","volume":"19","author":"B Mellstr\u00f6m","year":"1979","unstructured":"Mellstr\u00f6m B, Bertilsson L, Tr\u00e4skman L, Rollins D, \u00c5sberg M, Sj\u00f6qvist F (1979) Intraindividual similarity in the metabolism of amitriptyline and chlorimipramine in depressed patients. Pharmacology 19: 282?287","journal-title":"Pharmacology"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/BF00561800","volume":"6","author":"B Alexanderson","year":"1973","unstructured":"Alexanderson B (1973) Prediction of steady-state plasma levels of nortriptyline from single oral dose kinetics. A study in twins. Eur J Clin Pharmacol 6: 44?53","journal-title":"Eur J Clin Pharmacol"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0140-6736(77)91430-1","volume":"2","author":"A Mahgoub","year":"1977","unstructured":"Mahgoub A, Idle JR, Dring LG, Lancaster R, Smith RL (1977) Polymorphic hydroxylation of debrisoquine in man. Lancet 2: 584?586","journal-title":"Lancet"},{"key":"CR13","unstructured":"Idle JR, Smith RL (1984) The debrisoquine hydroxylation gene: a gene of multiple consequence. In: Lemberger L, Reidenberg M (eds) Proceedings of the Second World Conference on Clin Pharm Ther ASPET, Bethesda pp 148?164"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1016\/0006-2952(85)90533-7","volume":"34","author":"C Bahr Von","year":"1985","unstructured":"Von Bahr C, Spina E, Birgersson C, Ericson \u00d6, G\u00f6ranson M, Henthorn T, Sj\u00f6qvist F (1985) Inhibition of desmethylimipramine 2-hydroxylation by drugs in human liver microsomes. Biochem Pharmacol 34: 2501?2505","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"CR15","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/jps.2600700307","volume":"70","author":"RF Suckow","year":"1981","unstructured":"Suckow RF, Cooper TB (1981) Simultaneous determination of imipramine, desipramine and their 2-hydroxymetabolites in plasma by ion-pain reversed-phase high-performance liquid chromatography with amperometric detection. J Pharm Sci 70 (3): 257?261","journal-title":"J Pharm Sci"},{"issue":"Suppl 4","key":"CR16","first-page":"63","volume":"53","author":"RB Jones","year":"1977","unstructured":"Jones RB, Luskombe DK (1977) Plasma concentrations of clomipramine and its N-desmethylmetabolite in depressive patients following treatment with various dosage regimes of clomipramine. Postgrad Med J 53 [Suppl 4]: 63?76","journal-title":"Postgrad Med J"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/0024-3205(67)90218-4","volume":"6","author":"W Hammer","year":"1967","unstructured":"Hammer W, Sj\u00f6qvist F (1967) Plasma levels of monomethylated tricyclic antidepressants during treatment with imipramine-like compounds. Life Sci 6: 1895?1903","journal-title":"Life Sci"},{"key":"CR18","first-page":"565","volume":"9","author":"B Mellstr\u00f6m","year":"1981","unstructured":"Mellstr\u00f6m B, von Bahr C (1981) Demethylation and hydroxylation of amitriptyline, nortriptyline and 10-hydroxyamitriptyline in human liver microsomes. Drug Metab Dispos 9: 565?568","journal-title":"Drug Metab Dispos"},{"key":"CR19","first-page":"373","volume-title":"Frontiers in biochemical and pharmacological research in depression","author":"WZ Potter","year":"1984","unstructured":"Potter WZ, Matthew VR, Lane EA (1984) Active metabolites of antidepressants: Pharmacodynamics and relevant pharmacokinetics. In: Usdin E, \u00c5sberg M, Bertilsson L, Sj\u00f6qvist F (eds) Frontiers in biochemical and pharmacological research in depression. Raven Press, New York, pp 373?390"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/bmj.1.5798.463","volume":"1","author":"LF Gram","year":"1972","unstructured":"Gram LF, Overo KF (1972) Drug interaction inhibitory effect of neuroleptics on metabolism of tricyclic antidepressants in man. Br Med J 1: 463?465","journal-title":"Br Med J"},{"issue":"Suppl 2","key":"CR21","first-page":"11","volume":"1","author":"JR Boissier","year":"1975","unstructured":"Boissier JR, Tillement JP, Martin D, Pichot P (1975) Effets de la l\u00e9vom\u00e9promazine sur le m\u00e9tabolisme de l'imipramine chez l'homme. J Pharmacol Clin 1 (Suppl 2): 11?15","journal-title":"J Pharmacol Clin"},{"key":"CR22","first-page":"165","volume":"1","author":"LF Gram","year":"1975","unstructured":"Gram LF (1975) Effects of perphenazine on imipramine metabolism in man. Psychopharmacol Commun 1: 165?175","journal-title":"Psychopharmacol Commun"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1176\/ajp.139.1.104","volume":"139","author":"SG Siris","year":"1982","unstructured":"Siris SG, Cooper TB, Rifkin AE et al (1982) Plasma imipramine concentrations in patients receiving concomitant fluphenazine decanoate. Am J Psychiatry 139: 104","journal-title":"Am J Psychiatry"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/clpt.1983.40","volume":"3","author":"JL Bock","year":"1983","unstructured":"Bock JL, Nelson CJ, Gray S, Jatlow PL (1983) Desipramine hydroxylation. Variability and effect of antipsychotic drugs. Clin Pharmacol Ther 3: 322?328","journal-title":"Clin Pharmacol Ther"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1176\/ajp.137.10.1232","volume":"137","author":"JC Nelson","year":"1980","unstructured":"Nelson JC, Jatlow PL (1980) Neuroleptic effect on desipramine steady-state plasma concentrations. Am J Psychiatry 137: 1232?1234","journal-title":"Am J Psychiatry"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/00004714-198312000-00011","volume":"3","author":"J Hirschowitz","year":"1983","unstructured":"Hirschowitz J, Bennett JA, Zemlan FP, Gaiver DL (1983) Thioridazine effect on desipramine plasma levels. J Clin Psychopharmacol 3: 376?379","journal-title":"J Clin Psychopharmacol"},{"key":"CR27","first-page":"836","volume":"131","author":"LF Gram","year":"1974","unstructured":"Gram LF, Overo KF, Kirk L (1974) Influence of neuroleptics and benzodiazepines on metabolism of tricyclic antidepressants in man. Am J Psychiatry 131: 836?866","journal-title":"Am J Psychiatry"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"454","DOI":"10.2165\/00003088-198106060-00003","volume":"6","author":"S Loga","year":"1981","unstructured":"Loga S, Curry S, Lader M (1981) Interaction of chlorpromazine and nortriptyline in patients with schizophrenia. Clin Pharmacokinet 6: 454?462","journal-title":"Clin Pharmacokinet"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0024-3205(84)90332-1","volume":"34","author":"SV Otton","year":"1984","unstructured":"Otton SV, Inaba T, Kalow W (1984) Competitive inhibition of sparteine oxidation in human liver by ?-adrenoceptor antagonists and other cardiovascular drugs. Life Sci 34: 73?80","journal-title":"Life Sci"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/BF00615971","volume":"29","author":"T Lehmann","year":"1986","unstructured":"Lehmann T, Dayer P, Meyer UA (1986) Single dose quinidine treatment inhibits metoprolol oxidation in extensive metabolizers. Eur J Clin Pharmacol 29: 739?744","journal-title":"Eur J Clin Pharmacol"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00613523.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00613523\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00613523","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T03:42:42Z","timestamp":1554435762000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00613523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1986]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1986]]}},"alternative-id":["BF00613523"],"URL":"https:\/\/doi.org\/10.1007\/bf00613523","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1986]]}}}